Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 101-150 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT07219706
Dietary Fiber and Time Restricted Eating
NARecruiting
90 participants
Started: Dec 1, 2025 · Completed: Jun 30, 2027
2 conditions1 sponsor1 location
NCT06678516
Intermittent Fasting on the Blood Microbiome
NARecruiting
48 participants
Started: Dec 1, 2025 · Completed: Jan 10, 2026
1 condition1 sponsor2 locations
NCT06067399
Relationship Between Red Cell Distribution Width (RDW) and HbA1C in Patients With Type 2 Diabetes Mellitus After Glycemic Control
N/ARecruiting
250 participants
Started: Dec 1, 2025 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT06062628
Ketamine in Severe Traumatic Brain Injury
EARLY_PHASE1Recruiting
10 participants
Started: Dec 1, 2025 · Completed: Nov 30, 2026
2 conditions1 sponsor2 locations
NCT07017829
GT103 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic STK11 Mutant Non-Small Cell Lung Cancer
PHASE2Recruiting
28 participants
Started: Dec 1, 2025 · Completed: Dec 1, 2028
4 conditions1 sponsor1 location
NCT05783271
Validity of Parametric MRI Using VIRADS
NARecruiting
58 participants
Started: Dec 1, 2025 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT07203391
Tebentafusp and Roginolisib in Uveal Melanoma to Prolong T-cell Homeostasis
PHASE1Recruiting
8 participants
Started: Dec 1, 2025 · Completed: Dec 1, 2029
1 condition1 sponsor2 locations
NCT06424522
A Bowel Management Program (Retrograde Rectal Enema) for the Treatment of Low Anterior Resection Syndrome in Rectal Cancer Patients
NARecruiting
80 participants
Started: Dec 1, 2025 · Completed: Dec 31, 2028
2 conditions1 sponsor1 location
NCT06827860
Subcutaneous Talquetamab in Elderly Patients With Multiple Myeloma in Early Relapse
PHASE2Recruiting
23 participants
Started: Dec 1, 2025 · Completed: Jan 31, 2028
1 condition2 sponsors1 location
NCT07210164
Pre-habilitation Within ERAS Protocol for Gynecologic Oncology Surgery: The Pre_ERAS Study
NARecruiting
100 participants
Started: Dec 1, 2025 · Completed: Dec 30, 2029
11 conditions2 sponsors1 location
NCT06672419
Effectiveness of AI-Guided Exercise and Pain Neuroscience Education for Fibromyalgia (FIBROIA)
NARecruiting
50 participants
Started: Dec 1, 2025 · Completed: Jul 1, 2026
2 conditions3 sponsors1 location
NCT07011550
Phase 2, Single-arm Trial of BMS-986340 in Association With Nivolumab, Trifluridine/Tipiracil and Bevacizumab for Patients Refractory to Standard of Care Treatment and With Microsatellite-stable Colorectal Cancer
PHASE2Recruiting
40 participants
Started: Nov 30, 2025 · Completed: Jul 1, 2030
4 conditions2 sponsors1 location
NCT06638892
Using PrEP, Doing It for Ourselves
NARecruiting
1,000 participants
Started: Nov 30, 2025 · Completed: Jan 31, 2030
2 conditions3 sponsors1 location
NCT07094906
Handgrip Exercise Training and CKD
NARecruiting
50 participants
Started: Nov 30, 2025 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT07191327
Testing Personalized High-Definition Transcranial Direct Current Stimulation (HD-tDCS) as a Treatment of Posterior Cortical Atrophy
NARecruiting
50 participants
Started: Nov 30, 2025 · Completed: Sep 30, 2029
1 condition1 sponsor1 location
NCT06784336
Phase II Study of Resistant Potato Starch Plus Deferasirox to Improve Outcomes in Patients Undergoing Allogeneic Stem Cell Transplantation
PHASE2Recruiting
50 participants
Started: Nov 30, 2025 · Completed: Nov 30, 2029
1 condition3 sponsors1 location
NCT06735859
Eating Window and Sleep Disorders on Glycemic Control, Cardiovascular Risk, and Weight Loss
NARecruiting
48 participants
Started: Nov 30, 2025 · Completed: Nov 19, 2027
4 conditions2 sponsors1 location
NCT07083011
A Study of 68Ga-Fibroblast Activation Protein Inhibitor (FAPI) Positron Emission Tomography in Heart Failure
PHASE2Recruiting
35 participants
Started: Nov 30, 2025 · Completed: Jul 31, 2027
1 condition1 sponsor1 location
NCT07180849
Comparing the Antiplaque Effects of Novel Titania Nanoparticle Infused Fluoride Varnish vs Conventional Fluoride Varnish in Fixed Orthodontic Patients.
NARecruiting
20 participants
Started: Nov 30, 2025 · Completed: Dec 31, 2027
3 conditions1 sponsor1 location
NCT07097311
Study to Evaluate the Use of Triheptanoin in Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)
PHASE2Recruiting
24 participants
Started: Nov 30, 2025 · Completed: Mar 31, 2027
1 condition2 sponsors1 location
NCT07183111
Comparison of Traditional Instructions Vs AI Based Instructions With Customized Chat GPT as Remote Support System on Education of Orthodontic Patients
NARecruiting
60 participants
Started: Nov 30, 2025 · Completed: Nov 30, 2026
4 conditions1 sponsor1 location
NCT06948825
Effectiveness Study of a Lifestyle Intervention Versus Metformin in Mothers With Recent Gestational Diabetes
PHASE2Recruiting
60 participants
Started: Nov 30, 2025 · Completed: Aug 31, 2026
3 conditions4 sponsors1 location
NCT06456268
VibraCool Device to Reduce Pain and Opioid Use After Anterior Cruciate Ligament Reconstruction (ACLR)
NARecruiting
130 participants
Started: Nov 30, 2025 · Completed: Nov 30, 2026
5 conditions1 sponsor1 location
NCT04328584
Intraoperative Navigation for Surgically Precise Resection of the Chest (INSPIRE)
NARecruiting
20 participants
Started: Nov 30, 2025 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT06441006
Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis
PHASE2/PHASE3Recruiting
400 participants
Started: Nov 30, 2025 · Completed: Aug 31, 2031
3 conditions2 sponsors6 locations
NCT06367738
Investigating the Persisting Effects of a Single Dose of Psilocybin on Structural Plasticity in Healthy Older Adults
PHASE1Recruiting
40 participants
Started: Nov 30, 2025 · Completed: Dec 30, 2027
1 condition1 sponsor1 location
NCT06968195
Autologous CAR T Cells Targeting GPC3 (RPCAR01) for the Treatment of Advanced or Metastatic GPC3 Expressing Hepatocellular Carcinoma
PHASE1Recruiting
24 participants
Started: Nov 30, 2025 · Completed: May 30, 2029
6 conditions1 sponsor1 location
NCT06986174
A Phase 2 Study to Evaluate the Safety and Efficacy of Pacritinib in Relapsed or Refractory Waldenström Macroglobulinemia
PHASE2Recruiting
30 participants
Started: Nov 30, 2025 · Completed: Oct 1, 2032
4 conditions2 sponsors1 location
NCT06723743
Transcutaneous Vagus Nerve Stimulation for Attention and Memory
NARecruiting
30 participants
Started: Nov 30, 2025 · Completed: Feb 28, 2026
1 condition2 sponsors2 locations
NCT07220265
Impact of Phenylalanine Elevations on Brain and Cognition in Adult PKU Carriers
NARecruiting
36 participants
Started: Nov 30, 2025 · Completed: Apr 30, 2027
2 conditions2 sponsors1 location
NCT06207253
The Antimicrobial Potential of Diclofenac Sodium as an Intracanal Medicament
PHASE2/PHASE3Recruiting
48 participants
Started: Nov 30, 2025 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT07100782
Estradiol-mediated Inflammation and Central Sensitization in the Pathophysiology of Endometriosis-associated Pelvic Pain
PHASE3Recruiting
130 participants
Started: Nov 30, 2025 · Completed: Sep 30, 2028
2 conditions2 sponsors1 location
NCT05472909
Music Interventions During Wide-Awake Hand Surgery
NARecruiting
170 participants
Started: Nov 30, 2025 · Completed: Nov 30, 2026
2 conditions1 sponsor1 location
NCT07157254
A Safety and Efficacy Study of GTX-102 in Subjects With Deletion- or Nondeletion-type Angelman Syndrome (AS)
PHASE2Recruiting
60 participants
Started: Nov 30, 2025 · Completed: Jan 31, 2030
1 condition1 sponsor1 location
NCT06727305
MTOR Inhibitors in Older Adults
PHASE1/PHASE2Recruiting
60 participants
Started: Nov 30, 2025 · Completed: Nov 13, 2027
1 condition3 sponsors1 location
NCT06449313
Neoadjuvant Chemo-Immunotherapy and Surgical Resection in Locally Advanced Non-small Cell Lung Cancer With N3 Lymph Node Involvement
PHASE2Recruiting
21 participants
Started: Nov 30, 2025 · Completed: Sep 30, 2032
1 condition2 sponsors1 location
NCT06220396
CArdioMEtabolic Function and Reserve Capacity in Healthy Adults: The CAMERA Study
NARecruiting
80 participants
Started: Nov 30, 2025 · Completed: Jan 31, 2029
1 condition1 sponsor1 location
NCT07116434
Discovery Diabetes
NARecruiting
150 participants
Started: Nov 30, 2025 · Completed: Nov 30, 2027
1 condition1 sponsor1 location
NCT07192432
Gene Therapy for HER-Positive Cancer (SENTRY-HER2)
PHASE1/PHASE2Recruiting
27 participants
Started: Nov 30, 2025 · Completed: Oct 31, 2033
1 condition1 sponsor2 locations
NCT06532474
Exploring the Physiologic, Pharmacodynamic, and Clinical Responses of Skeletal Muscle in Patients With Spinal Muscular Atrophy Treated With SMN-Directed Therapies
N/ARecruiting
24 participants
Started: Nov 30, 2025 · Completed: Mar 31, 2027
1 condition2 sponsors1 location
NCT05770544
DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusion-positive Cancers.
PHASE2/PHASE3Recruiting
30 participants
Started: Nov 30, 2025 · Completed: Oct 31, 2029
11 conditions5 sponsors27 locations
NCT07078461
Investigating the Safety and Efficacy of the 1927-nm Thulium Laser in Keratosis Pilaris
NARecruiting
25 participants
Started: Nov 30, 2025 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT07213479
Feasibility and Acceptability of Isometric Exercise and Lifestyle Change for the Management of Hypertension
NARecruiting
70 participants
Started: Nov 30, 2025 · Completed: Feb 29, 2028
1 condition2 sponsors1 location
NCT05768802
Evaluation of Myoelectric Implantable Recording Array (MIRA) in Participants With Transradial Amputation
NARecruiting
5 participants
Started: Nov 30, 2025 · Completed: Dec 31, 2029
2 conditions3 sponsors1 location
NCT06998966
Optimizing Proton Pump Inhibitors (PPI) Prescribing With EHR-Based Decision Support
NARecruiting
372 participants
Started: Nov 30, 2025 · Completed: Nov 30, 2026
3 conditions2 sponsors1 location
NCT07217145
PREVENT HPV -Related Cancers Trial
NARecruiting
519 participants
Started: Nov 30, 2025 · Completed: Feb 28, 2026
3 conditions5 sponsors1 location
NCT07217015
A Study of KT-621 Administered Orally to Participants With Moderate to Severe Atopic Dermatitis
PHASE2Recruiting
200 participants
Started: Nov 30, 2025 · Completed: Jun 30, 2028
1 condition1 sponsor2 locations
NCT06625190
Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
PHASE1/PHASE2Recruiting
27 participants
Started: Nov 30, 2025 · Completed: Feb 28, 2030
13 conditions1 sponsor1 location
NCT07007520
A Study to Evaluate the Food Effect on the Pharmacokinetics of DA-5223 in Healthy Adult Subjects
PHASE1Recruiting
38 participants
Started: Nov 30, 2025 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT06726590
Interprofessional Pharmacogenomics (IPGx) Registry and Repository
N/ARecruiting
3,000 participants
Started: Nov 30, 2025 · Completed: Nov 30, 2029
9 conditions1 sponsor1 location